Last reviewed · How we verify

Fisrt period TWLO_C

Dong-A ST Co., Ltd. · Phase 1 active Small molecule

Fisrt period TWLO_C is a Small molecule drug developed by Dong-A ST Co., Ltd.. It is currently in Phase 1 development. Also known as: "Dong-a Bepotastine Besilate Tab".

At a glance

Generic nameFisrt period TWLO_C
Also known as"Dong-a Bepotastine Besilate Tab"
SponsorDong-A ST Co., Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Fisrt period TWLO_C

What is Fisrt period TWLO_C?

Fisrt period TWLO_C is a Small molecule drug developed by Dong-A ST Co., Ltd..

Who makes Fisrt period TWLO_C?

Fisrt period TWLO_C is developed by Dong-A ST Co., Ltd. (see full Dong-A ST Co., Ltd. pipeline at /company/dong-a-st-co-ltd).

Is Fisrt period TWLO_C also known as anything else?

Fisrt period TWLO_C is also known as "Dong-a Bepotastine Besilate Tab".

What development phase is Fisrt period TWLO_C in?

Fisrt period TWLO_C is in Phase 1.

Related